Where is TIAP's headquarters located?

TIAP's headquarters is located in Toronto (Canada).

How big is TIAP's investment team?

TIAP has a team of 15, including 9 partners.

How many companies has TIAP invested in?

TIAP has invested in 64 companies, including Flybits & ODAIA.

Which companies has TIAP invested in lately?

Synakis & Grey Matter Neurosciences are the latest investments by TIAP.

How many exits has TIAP been involved in?

TIAP's portfolio has seen 10 acquisitions.

TIAP - 2026 Investor Profile, Portfolio, Team & Investment Trends

1. Flybits

Flybits is a banking channel for enterprises. It features Context-as-a-Service platform that enables banks and other enterprises to create and deliver context-aware mobile applications. It features tools for creating personalized mobile experiences on top of traditional app development and simple location-based services. It supports the iOS and Android devices and helps in scaling to handle the data sources of the emerging internet-of-things.

Key facts about Flybits

Founded Year: 2013
Location: Toronto (Canada)
Stage: Series C
Total Funding till date: $50M
Employee Count: 55 as on Aug 31, 2026
Investors: Information Venture Partners, Mastercard and 18 Others
Latest Funding Round: Series C, Jul 16, 2019, $*****
Highlight: Editors' Pick

2. ODAIA

Provider of AI-powered intelligence platform for pharmaceutical commercial and sales teams. The platform delivers relevant targets, prioritized call lists, and personalized insights. It helps sales representatives engage with healthcare professionals. The platform identifies trends and patterns in engagements, empowering managers with actionable insights. It offers dynamic segmentation and targeting to optimize commercial resources.

Key facts about ODAIA

Founded Year: 2018
Location: Toronto (Canada)
Stage: Series B
Total Funding till date: $44.5M
Employee Count: 108 as on Aug 31, 2026
Investors: Inovia Capital, Threshold and 18 Others
Latest Funding Round: Series B, May 01, 2023, $*****
Highlight: Editors' Pick

3. Deep Genomics

AI-powered platform for RNA biology to accelerate genetic therapy discovery. It focuses on untangling complex RNA data to identify novel targets and therapeutic candidates for genetic conditions. Its offers proprietary AI platform including the flagship model BigRNA that uses machine learning to analyze vast RNA biology data, identify therapeutic targets, and evaluate potential therapeutic candidates efficiently than traditional approaches. The technology helps accelerate early stages of drug discovery and design of RNA-based therapies.

Key facts about Deep Genomics

Founded Year: 2014
Location: Toronto (Canada)
Stage: Series C
Total Funding till date: $238M
Employee Count: 110 as on Sep 30, 2026
Investors: Fidelity Investments, Deep Learning and 16 Others
Latest Funding Round: Series C, Jul 28, 2021, $*****
Highlight: Editors' Pick

4. BlueDot

Provider of infectious disease intelligence platform. It models how infectious diseases can spread and impact populations globally by analyzing big data such as the annual movements, human, animal, and insect population data, climate data from satellites, and news reports of disease outbreaks.

Key facts about BlueDot

Founded Year: 2013
Location: Toronto (Canada)
Valuation: $*****
Stage: Series A
Total Funding till date: $9.95M
Employee Count: 93 as on Aug 31, 2026
Investors: MaRS Discovery District, Golden Ventures and 6 Others
Latest Funding Round: Grant (prize money), Jan 17, 2023, $*****
Highlight: Editors' Pick

5. EBT Medical

EBT Medical is developing non-invasive neurostimulation therapies and disease state support systems for pelvic floor disorders, starting with overactive bladder. It delivers long-lasting pharmaceutical or invasive therapy-equivalent efficacy without the side-effects, invasiveness, or costs that are typically associated with those therapies.

Key facts about EBT Medical

Founded Year: 2014
Location: Toronto (Canada)
Stage: Series A
Total Funding till date: $10M
Employee Count: 11 as on Aug 31, 2026
Investors: Canadian Institutes of Health Research, Genesys Capital and 8 Others
Latest Funding Round: Series A, Nov 19, 2019, $*****

View the full list of portfolio companies

TIAP has invested in 64 companies over the last 16 years, with an average of 1 new investment annually in the last 10 years. In 2025, it made 1 investment, while as of May 2026, it has made 1 investment in this year. Its most recent first time investment was in Synakis and most recent follow-on round was in Radiant Biotherapeutics.

Here are TIAP's Year-on-Year Investment Trends:

Year	No. of Investments
Year	1^st Round	Follow-on	Total
2026 (YTD)	1	0	1
2025	1	0	1
2024	1	1	2
2023	1	0	1
2022	1	0	1
2021	1	0	1
2020	0	0	0
2019	3	0	3
2018	0	1	1
2017	1	0	1

View all investments by TIAP

TIAP has made 24 investments in Seed stage with an average round size of $2.64M, 3 investments in Series A stage with an average round size of $3.94M and 1 investment in Grant (prize money) stage with an average round size of $12.5K.

Here are TIAP's investments by stage:

Stage of entry	No. of Investments
Seed	24
Series A	3
Grant (prize money)	1

Note: We have considered here, only first round of investments

View all investments by TIAP

TIAP has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, HealthTech, High Tech and Sustainability Tech. Notably, it has invested in 55 Tech companies, 48 Enterprise (B2B) companies, 32 Software companies and at least 12 companies focusing on Consumer (B2C).

Here are TIAP's investments by sector:

Sector	No. of Investments
Life Sciences	14
Enterprise Applications	10
HealthTech	7
High Tech	6
Sustainability Tech	4
Others	15

Note: We have considered here, only first round of investments

View all investments by TIAP

TIAP has made most investments in Canada (25), followed by United States where it has made 3 investments.

Here are TIAP's investments by geography:

Country	No. of Investments
Canada	25
United States	3

Note: We have considered here, only first round of investments

View all investments by TIAP

TIAP has made 1 investments in 2026 so far - Synakis.

Here are the most recent investments by TIAP:

Filter this list

Date	Company	Location	Round Details	Round Amount	Co-Investors
May 25, 2026	Synakis	Canada	Seed	2631	Ontario Centre of Innovation ... [+2]
Jan 23, 2025	Grey Matter Neurosciences	Canada	Seed	4761	Wittington Ventures [+2]
Sep 11, 2024	Radiant Biotherapeutics	Canada	Series A	2593	Gates [+5]
Sep 05, 2024	HDAX	Canada	Seed	4880	SeedFolio [+3]
Apr 25, 2023	Radiant Biotherapeutics	Canada	Seed	5695	Amplitude [+4]

See more recent investments made by TIAP

10 companies from TIAP's portfolio have been acquired. The most recent acquisition was Mutuo Health Solutions in Nov 2025 by Wellstar for $*****.

Here are TIAP's portfolio companies that got acquired most recently:

Filter this list

Company	Acquisition Date	First Invested on	First Round of Investment	Round Size
Mutuo Health Solutions	Nov 02, 2025	Apr 2019	Grant (prize money)	9025
Bitnobi	Jan 16, 2025	-	-	2929
QD Solar	Jun 18, 2024	Feb 13, 2017	Series A	8969
Slyce	Sep 22, 2021	-	-	2030
CoHealth	Oct 28, 2020	-	-	3464

View all acquired companies in TIAP's portfolio

TIAP has a team of 15 members including 9 Partners and 2 Principals located in Canada. TIAP's team does not sit on the board of any company as of now.

Here is a list of top team members in TIAP:

Name	Designation	Location	Board Memberships	Contact Details
Angus Grant	Partner	-	-	1 Email
Ido Kaminsky	Partner	-	-	1 Email
Mobeen Lalani	Partner	Toronto	-	2 Emails
Philip Goldbach	Partner	-	-	1 Email
Prakash Gowd	Partner	-	-	1 Email
Sohaib Siddiqui	Partner	-	-	1 Email
Andy J. Smith	Partner	Toronto	-	-
Jessica Chutter	Partner	-	-	1 Email
Conal Slobodin	Partner	Ottawa	-	-
Michael Wasserman	Principal	Toronto	-	-
Tanya Borsuk	Principal	-	-	1 Email

View team details of TIAP

Over the past 16 years, 80 investors have co-invested in TIAP's portfolio companies. This includes funds and angels.

Invested before TIAP: Mitacs, Canadian Glycomics Network and 7 others have invested in rounds before TIAP. There is 1 company where Mitacs has invested before TIAP and 1 company where Canadian Glycomics Network has invested before TIAP.
Top Co-investors of TIAP: 34 investors entered a company along with TIAP. These include investors like Ontario Centre of Innovation (5 companies).
Invested after TIAP: A total of 37 investors have invested in TIAP's portfolio after their investments. Top Investors include Canadian Space Agency (2 companies) and Y Combinator (2 companies).